Pharmaceutical composition of a papillomavirus inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9670159
APP PUB NO 20150152051A1
SERIAL NO

14399354

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a pharmaceutical composition including a compound of general formula (I) combined with a solvent and a viscosity-enhancing agent, as well as to the use thereof as a drug, in particular for treating and preventing infection with the papillomavirus, and to the method for preparing same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVIRAGEN THERAPEUTICS INC2500 NORTHWINDS PARKWAY SUITE 100 ALPHARETTA GA 30009

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blumenfeld, Marta Paris, FR 53 569
Compere, Delphine Sceaux, FR 14 67
Francon, Patricia Bois le Roi, FR 1 0
Hutin, Michel Cernay la Ville, FR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 6, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00